High-risk HPV detection and concurrent HPV 16 and 18 typing with Abbott RealTime High Risk HPV test
Authors:
- Shihai HuangSHShihai Huang
- 1 July 2009
- journal article
- research article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 45, S25-S28
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and olderInternational Journal of Cancer, 2008
- Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing CountriesVaccine, 2008
- Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical CancerNew England Journal of Medicine, 2007
- HPV DNA testing in cervical cancer screening: From evidence to policiesGynecologic Oncology, 2006
- Chapter 9: Clinical applications of HPV testing: A summary of meta-analysesVaccine, 2006
- HPV‐mediated cervical carcinogenesis: concepts and clinical implicationsThe Journal of Pathology, 2005
- The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical PracticeJNCI: Journal of the National Cancer Institute, 2005
- Human papillomavirus is a necessary cause of invasive cervical cancer worldwideThe Journal of Pathology, 1999
- Epidemiologic Evidence and Human Papillomavirus Infection as a Necessary Cause of Cervical CancerJNCI: Journal of the National Cancer Institute, 1999
- Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reactionInternational Journal of Cancer, 1994